This is in reference to our letter dated February 23, 2022, enclosing therewith a Postal Ballot Notice dated February 8, 2022 seeking consent of Members of the Company through Ordinary Resolution for Material Related Party Transactions to be entered into by the Company with AstraZeneca UK Limited. Pursuant to Regulation 44 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that the said Resolution has been passed by Members of the Company with requisite majority. We are enclosing herewith the Voting Results along with the Scrutinizer's Report and the same are being placed on the Company's website at http://www.astrazeneca.com/india and website of National Securities Depository Limited at www.evoting.nsdl.com.